BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22425309)

  • 1. Expression of late viral proteins is restricted in nasal mucosal leucocytes but not in epithelial cells during early-stage equine herpes virus-1 infection.
    Gryspeerdt AC; Vandekerckhove AP; Baghi HB; Van de Walle GR; Nauwynck HJ
    Vet J; 2012 Aug; 193(2):576-8. PubMed ID: 22425309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of viral envelope proteins in equine herpesvirus 1-infected blood mononuclear cells during cell-associated viremia.
    van der Meulen K; Caij B; Pensaert M; Nauwynck H
    Vet Microbiol; 2006 Mar; 113(3-4):265-73. PubMed ID: 16387454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenic potential of equine alphaherpesviruses: the importance of the mononuclear cell compartment in disease outcome.
    Osterrieder N; Van de Walle GR
    Vet Microbiol; 2010 Jun; 143(1):21-8. PubMed ID: 20202764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination.
    Minke JM; Fischer L; Baudu P; Guigal PM; Sindle T; Mumford JA; Audonnet JC
    Vet Immunol Immunopathol; 2006 May; 111(1-2):47-57. PubMed ID: 16580075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Equine alphaherpesviruses (EHV-1 and EHV-4) differ in their efficiency to infect mononuclear cells during early steps of infection in nasal mucosal explants.
    Vandekerckhove AP; Glorieux S; Gryspeerdt AC; Steukers L; Van Doorsselaere J; Osterrieder N; Van de Walle GR; Nauwynck HJ
    Vet Microbiol; 2011 Aug; 152(1-2):21-8. PubMed ID: 21536394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of the ORF2 gene of the neuropathogenic equine herpesvirus type 1 strain Ab4 reduces virulence while maintaining strong immunogenicity.
    Schnabel CL; Wimer CL; Perkins G; Babasyan S; Freer H; Watts C; Rollins A; Osterrieder N; Wagner B
    BMC Vet Res; 2018 Aug; 14(1):245. PubMed ID: 30134896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of equine herpesvirus type 1 (EHV-1) infection on the migration of monocytic cells through equine nasal mucosa.
    Baghi HB; Nauwynck HJ
    Comp Immunol Microbiol Infect Dis; 2014 Dec; 37(5-6):321-9. PubMed ID: 25456193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equine herpesvirus type-1 modulates CCL2, CCL3, CCL5, CXCL9, and CXCL10 chemokine expression.
    Wimer CL; Damiani A; Osterrieder N; Wagner B
    Vet Immunol Immunopathol; 2011 Apr; 140(3-4):266-74. PubMed ID: 21349590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine responses to EHV-1 infection in immune and non-immune ponies.
    Coombs DK; Patton T; Kohler AK; Soboll G; Breathnach C; Townsend HG; Lunn DP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):109-16. PubMed ID: 16473413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-mediated immunity evaluation in foals infected with virulent equine herpesvirus-1 by multi-parameter flow cytometry.
    Platt R; Sponseller BA; Chiang YW; Roth JA
    Vet Immunol Immunopathol; 2010 Jun; 135(3-4):275-81. PubMed ID: 20116862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Equine herpesvirus 1 glycoprotein D expressed in E. coli provides partial protection against equine herpesvirus infection in mice and elicits virus-neutralizing antibodies in the horse.
    Weerasinghe CU; Learmonth GS; Gilkerson JR; Foote CE; Wellington JE; Whalley JM
    Vet Immunol Immunopathol; 2006 May; 111(1-2):59-66. PubMed ID: 16473414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An equine herpesvirus type 1 recombinant with a deletion in the gE and gI genes is avirulent in young horses.
    Matsumura T; Kondo T; Sugita S; Damiani AM; O'Callaghan DJ; Imagawa H
    Virology; 1998 Mar; 242(1):68-79. PubMed ID: 9501037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody and cellular immune responses following DNA vaccination and EHV-1 infection of ponies.
    Soboll G; Hussey SB; Whalley JM; Allen GP; Koen MT; Santucci N; Fraser DG; Macklin MD; Swain WF; Lunn DP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):81-95. PubMed ID: 16549215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infection of peripheral blood mononuclear cells with neuropathogenic equine herpesvirus type-1 strain Ab4 reveals intact interferon-α induction and induces suppression of anti-inflammatory interleukin-10 responses in comparison to other viral strains.
    Wagner B; Wimer C; Freer H; Osterrieder N; Erb HN
    Vet Immunol Immunopathol; 2011 Sep; 143(1-2):116-24. PubMed ID: 21764140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The deletion of the ORF1 and ORF71 genes reduces virulence of the neuropathogenic EHV-1 strain Ab4 without compromising host immunity in horses.
    Wimer CL; Schnabel CL; Perkins G; Babasyan S; Freer H; Stout AE; Rollins A; Osterrieder N; Goodman LB; Glaser A; Wagner B
    PLoS One; 2018; 13(11):e0206679. PubMed ID: 30440016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual infections of equine herpesvirus 1 and equine arteritis virus in equine respiratory mucosa explants.
    Zhao J; Negussie H; Laval K; Poelaert KC; Nauwynck HJ
    Virus Res; 2016 Jul; 220():104-11. PubMed ID: 27117322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inoculation of mares and very young foals with EHV-1 glycoproteins D and B reduces virus shedding following respiratory challenge with EHV-1.
    Foote CE; Raidal SL; Pecenpetelovska G; Wellington JE; Whalley JM
    Vet Immunol Immunopathol; 2006 May; 111(1-2):97-108. PubMed ID: 16504306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals.
    Foote CE; Love DN; Gilkerson JR; Rota J; Trevor-Jones P; Ruitenberg KM; Wellington JE; Whalley JM
    Vet Immunol Immunopathol; 2005 May; 105(1-2):47-57. PubMed ID: 15797474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mutations in the US2 and glycoprotein B genes of the equine herpesvirus 1 vaccine strain RacH have no effects on its attenuation].
    Neubauer A; Meindl A; Osterrieder N
    Berl Munch Tierarztl Wochenschr; 1999 Sep; 112(9):351-4. PubMed ID: 10507185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of equine herpesvirus-specific effector and memory cytotoxic immunity in the equine upper respiratory tract.
    Breathnach CC; Yeargan MR; Timoney JF; Allen GP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):117-25. PubMed ID: 16472871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.